FDA approves preventive migraine treatment

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

Posted: May 19, 2018 5:18 AM

(CNN) -- Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

On Thursday, the US Food and Drug Administration approved Aimovig for the preventive treatment of migraines in adults with episodic or chronic migraines. Episodic migraine is when symptoms occur zero to 14 days each month; symptoms of chronic migraine occur 15 days or more a month.

Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, or CGRP, a molecule that is involved in migraine attacks. Aimovig targets that molecule's receptor in your body.

The treatment, administered through monthly self-injections, requires a prescription and could be available to patients within a week. Aimovig is expected to cost $575 monthly or $6,900 annually in the United States.

There are three other migraine treatments in this newly emerging class of drugs.

Those drugs target the CGRP molecule itself, instead of its receptor. They are experimental but, if approved, might be made available to patients as early as this fall for one and next year for the others, said Dr. Stewart Tepper, director of the Dartmouth Headache Center at Dartmouth-Hitchcock Medical Center in New Hampshire, who was a clinical investigator in the Aimovig trials.

"When CGRP is released, outside of the brain, it causes inflammation and blood vessel dilation -- the blood vessels get big -- and that combination of inflammation and blood vessels getting big is the pain of migraine," said Tepper, who is also a professor of neurology at the Geisel School of Medicine at Dartmouth College.

Migraine is three times more common in women than in men and affects more than 10% of people worldwide, the FDA noted. In the US, about 12% of the population gets migraine headaches.

What was found in clinical trials
The effectiveness of Aimovig was evaluated in three key clinical trials.

The first included 955 people with a history of episodic migraine. Over the course of six months, those who received the treatment experienced one or two fewer monthly migraine days, on average, compared with a placebo.

The second study included 577 patients with a history of episodic migraine. Over the course of three months, those who received Aimovig treatment experienced one fewer migraine day per month.

The third study evaluated 667 patients with a history of chronic migraine. Over the course of three months, patients treated with Aimovig experienced, on average, 2½ fewer monthly migraine days than those receiving a placebo.

"It may not get rid of all of them, but it really dramatically improves the frequency, severity and duration of the migraine attacks," Tepper said of the new treatment.

Patients "still will need to take something when they get a migraine attack, but this is the first designer medication to prevent migraine rather than treat as needed," he said.

In the clinical studies, the most common adverse side effects were pain at the injection site and constipation. The drug can be injected in the thigh, the abdomen or the outer area of the upper arm.

"The field is excited about a new drug that is specifically targeted for migraine mechanisms," said Dr. Teshamae Monteith, assistant professor of clinical neurology at the University of Miami and a member of the American Academy of Neurology, who was not involved in the development of the drug.

"Not only does the data show that it's effective for people who have what we call episodic migraine, but it's also effective for people who have chronic migraine," Monteith said.

"If you can imagine, a patient with chronic migraine has at least 15 days -- half the month -- with some type of headache, and eight days out of that month, it's what you would call a moderate to severe headache with associated symptoms, such as light sensitivity, sound sensitivity, some cognitive dysfunction, [gastrointestinal] symptoms and sometimes visual and motor symptoms," she said. "Patients can have fatigue, concentration impairment, neck stiffness and sometimes mood changes as well."

By Friday, Monteith was already receiving requests for prescriptions and questions about Aimovig from her patients, including Helene Good, who uses injections of Botox to treat her migraines.

'It's really exciting'
"I first heard about it when it showed up on my phone this morning as an article in my news, and I just happened to be on my way to see Dr. Monteith for my treatment today," Good said Friday.

"I read it to my spouse on the way over, and it's really exciting," said Good, a 63-year-old Miami resident who has had migraines since she was in her late teens.

"It's not like just having a bad headache. For me, it manifests in other ways," she said. "One side of my face droops, which sort of looks like I've had a mini stroke. I'm a pretty fast speaker, but my speech gets very slow."

When it comes to migraine treatment options, "you're always hoping and looking for hope," she said.

Treatment options for migraine sufferers typically depend on the frequency and severity of the migraine attacks. Patients who have episodic migraine usually rely on pain medications to treat the migraine pain. To avoid episodes, some patients may stay away from triggers, such as certain foods, lack of sleep or stress.

Before Aimovig, "the FDA-approved preventive medications for episodic migraine were only four. Two of them are beta blockers, anti-blood pressure medicines, and two of them are anti-epilepsy drugs," Tepper said.

"There was one FDA-approved treatment for chronic migraine, which was Botox," he said. For patients, "with our current preventive medicines, they have to take oral medicine every day, with the exception of Botox, which is given in 31 injections every 12 weeks."

Yet a problem with many of those other treatment options is that some are traditionally used for other disorders and have side effects, Monteith said.

"Not only are some of the drugs not effective for every patient, but then there's this issue with tolerability," she said. "Some of these drugs are not well-tolerated. In the right person, it's great, but certainly we need some other option."

Additionally, there are medical devices such as a FDA-approved nerve-stimulating "tiara" called Cefaly, another nerve-stimulating device called gammaCore and even an approach called transcranial magnetic stimulation. Some patients have turned to acupuncture for migraine therapy.

"As a headache specialist, there are a number of treatments that are available for our patients preventively for migraine, but many of them are associated with a lot of different side effects, and we've been waiting for the day when we can have a medication that specifically targets migraine and prevents it in this unique modality and is associated with few side effects," said Dr. Thomas Berk, headache neurologist at NYU Langone Health, who was not involved in the development of the new treatment.

"I've had a number of requests already from patients asking, is it possible to get it to them quickly? What are the ways of getting it, and the big question being, is my insurance going to cover it, which is a question that we don't really know particularly yet," he said. "Everyone's excited about it."

Terre Haute
Partly Cloudy
23° wxIcon
Hi: 37° Lo: 22°
Feels Like: 16°
Robinson
Partly Cloudy
20° wxIcon
Hi: 38° Lo: 21°
Feels Like: 20°
Indianapolis/Eagle Creek
Cloudy
24° wxIcon
Hi: 31° Lo: 21°
Feels Like: 13°
Paris
Mostly Cloudy
20° wxIcon
Hi: 35° Lo: 21°
Feels Like: 11°
Mattoon/Charleston
Partly Cloudy
16° wxIcon
Hi: 38° Lo: 20°
Feels Like: 7°
Terre Haute
Mostly Cloudy
23° wxIcon
Hi: 35° Lo: 21°
Feels Like: 16°
Terre Haute
Partly Cloudy
23° wxIcon
Hi: 37° Lo: 22°
Feels Like: 16°
Cloudy, Breezy & Cold
WTHI Planner
WTHI Temps
WTHI Radar

Latest Video

Image

Wednesday: Becoming sunny. Breezy. High: 38°

Image

THN Shakamak

Image

West Vigo Bloomfield

Image

Loogootee Evan Memorial

Image

North Daviess Dugger Union

Image

Vincennes Rivet Evan Central

Image

Vin Lincoln Evan Mater Dei

Image

TH North Nothview

Image

Caitlyn Newton

Image

Climate change education

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1076532

Reported Deaths: 20153
CountyCasesDeaths
Cook4358889065
DuPage692851153
Will58408870
Lake53439886
Kane46063677
Winnebago26295407
Madison24398463
St. Clair22343426
McHenry21712248
Champaign15485102
Peoria15054241
Sangamon14548235
McLean13244159
Tazewell11944245
Rock Island11919303
Kankakee11488179
Kendall971578
LaSalle9478247
Macon8836179
Vermilion7538113
DeKalb749192
Adams7371117
Williamson6196116
Boone554977
Whiteside5261173
Clinton503285
Coles470380
Ogle460371
Knox4589142
Grundy438754
Effingham431169
Jackson418767
Henry401476
Marion3994112
Macoupin384994
Franklin384769
Randolph371568
Livingston364766
Monroe358770
Stephenson353274
Jefferson3435104
Morgan325989
Woodford320266
Logan309456
Montgomery305342
Lee304872
Bureau300484
Christian298673
Fayette291153
Perry267060
Iroquois259756
Fulton256949
Jersey222556
Lawrence217630
McDonough215051
Saline203053
Douglas199533
Union199332
Shelby197035
Crawford176134
Cass175131
Bond173824
Warren158644
Pike154346
Richland153644
Wayne152043
Hancock148634
Jo Daviess148524
Clark147730
Washington145225
Edgar144353
Carroll142633
Ford139049
Moultrie137428
White133430
Clay131240
Greene125742
Johnson121115
Wabash117914
Piatt117416
Mercer117229
Mason116640
De Witt114727
Cumberland108527
Jasper104015
Massac101831
Menard88010
Hamilton71717
Marshall67013
Schuyler62416
Pulaski6133
Brown61011
Stark49320
Edwards4629
Henderson45316
Calhoun4404
Alexander3897
Gallatin3884
Scott3851
Putnam3462
Hardin3038
Pope2472
Unassigned1050
Out of IL320

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 595436

Reported Deaths: 9466
CountyCasesDeaths
Marion822851311
Lake44626670
Allen32165543
Hamilton28684308
St. Joseph26917378
Elkhart24173343
Vanderburgh18856236
Tippecanoe17638125
Johnson14687289
Porter14513163
Hendricks14010242
Madison10715216
Vigo10540177
Clark10349135
Monroe9189108
Delaware8956134
LaPorte8867158
Howard7982140
Kosciusko791380
Warrick652994
Hancock646999
Bartholomew631096
Floyd6205107
Wayne5984159
Grant5874110
Dubois547175
Boone538867
Morgan524192
Henry497764
Marshall495384
Cass475362
Dearborn464545
Noble463157
Jackson417846
Shelby405680
Lawrence383876
Clinton367840
Gibson360058
DeKalb339163
Montgomery338152
Harrison333643
Knox329839
Miami312743
Steuben309343
Adams297435
Whitley297225
Wabash294947
Ripley294345
Putnam288047
Jasper285234
Huntington284959
White269138
Daviess263073
Jefferson253838
Decatur243482
Fayette242948
Greene237062
Posey234427
Wells231347
LaGrange225061
Clay219032
Scott218538
Randolph209845
Jennings193935
Sullivan189632
Spencer184319
Fountain180527
Washington179321
Starke172743
Jay163922
Fulton161130
Owen161137
Carroll153915
Orange152933
Rush151618
Perry149327
Vermillion145833
Franklin144433
Tipton129232
Parke12918
Pike114326
Blackford109222
Pulaski95337
Newton89821
Brown85931
Benton85310
Crawford7719
Martin70713
Warren6637
Switzerland6235
Union6146
Ohio4727
Unassigned0374